We support every stage of your AAV research workflow.
Whether your research focuses on gene delivery, functional genomics, CRISPR editing, disease modelling, neuroscience, or preclinical studies, our specialists can help identify the most suitable Takara Bio AAV solution for your application.
Build recombinant AAV constructs efficiently with seamless cloning tools that support gene insertion, promoter selection, and vector engineering.
Featured Technologies
Generate high-titer recombinant AAV particles using optimized packaging systems that eliminate the need for a helper virus.
Featured Technologies
Recover AAV particles from producer cells and reduce sample volume using streamlined solutions designed for efficient downstream processing.
Featured Technologies
Obtain highly purified AAV particles through rapid, column-based workflows suitable for multiple serotypes and research applications.
Featured Technologies
Quantify AAV vector genomes using a standardized real-time PCR workflow for consistent assessment of viral preparations.
Featured Technologies
Deliver genes into cultured cells or in vivo research models for gene-function analysis, disease modelling, neuroscience, and preclinical research.
Featured Technologies
Enable AAV-mediated delivery of genome-editing components for functional genomics and editing studies, including difficult-to-transfect cell models.
Featured Technologies
Confirm successful delivery and evaluate downstream expression using sensitive reverse transcription and real-time PCR technologies.
Featured Technologies
AAV Brochure
Flyer
